Literature DB >> 29133633

Altered tear inflammatory profile in Indian keratoconus patients - The 2015 Col Rangachari Award paper.

Rohit Shetty1, Rashmi Deshmukh1, Arkasubhra Ghosh2, Swaminathan Sethu2, Chaitra Jayadev1.   

Abstract

PURPOSE: Conventionally, keratoconus (KC) has been considered a noninflammatory corneal ectatic disorder. Recent evidence suggests a possible role of inflammation in the pathogenesis of KC. Hence, we analyzed the levels of inflammatory factors in the tear fluid of Indian KC patients.
METHODS: Tear fluid samples were collected from age- and sex-matched healthy controls and KC patients (with different grades). The levels of the inflammatory factors in tears were analyzed using cytometric bead array (Human Soluble Protein Flex Set System, BD Biosciences) for levels of interleukin-1α (IL-1α), IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-9, IL-10, IL-12p70, IL-23p40, IL-13, IL-17A, IL-17F, IL-21, interferon-α (IFNα), IFNγ, tumor necrosis factor-α, CCL2/monocyte chemotactic protein-1, CCL4/macrophage inflammatory protein-1β (MIP-1β), MIP-1α, CCL5/RANTES, CXCL10/IP10, ICAM1, CD62E, vascular endothelial growth factor and transforming growth factor β.
RESULTS: An increase in Kmax and Kmean, and a decrease in central corneal thickness was observed with increasing grades of KC. Tear analysis showed that most of the tear soluble factors, including cytokines, chemokines, growth factors and cell adhesion molecules were significantly elevated in the KC patients compared to the controls.
CONCLUSION: Our findings suggest that inflammatory factors associated with KC may play a role in its pathogenesis. This opens the potential to explore anti-inflammatory strategies to either halt or delay the progression of KC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29133633      PMCID: PMC5700575          DOI: 10.4103/ijo.IJO_233_17

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


Keratoconus (KC) is a progressive corneal ectatic disorder characterized by stromal thinning, protrusion and the resultant irregular astigmatism and myopia.[12] Conventionally, it has been classified as a noninflammatory disease, as the classical signs of inflammation (redness, heat, swelling, and pain) are not apparent in KC.[2] Recently, a combination of oxidative stress, genetic and environmental risk factors, and atopic eye disease has been suggested to play a role in KC disease pathology.[3] Despite the absence of obvious inflammation, studies have demonstrated inflammatory factors such as matrix metalloproteinases (MMPs) in tears of patients with clinical and subclinical KC.[456] Furthermore, information regarding the tear inflammatory factors profile in Indian KC patients is sparse. Although knowledge about the etiopathogenesis of KC is evolving, the molecular factors that drive the loss of corneal structure integrity are poorly understood. Altered collagen structure leading to biomechanical weakening as well as deregulated epithelial and stromal proteins have been demonstrated in KC.[78] It is well known from the biology of extracellular matrix modeling that inflammatory factors do play a key role in the remodeling process. Therefore, to determine the possible inflammatory status in KC, we evaluated the levels of inflammatory factors in tears of KC patients with different grades, compared to controls.

Methods

Cohort details

This study was performed in accordance with the tenets of the Declaration of Helsinki with prior approval from the Narayana Nethralaya Institutional Review Board, as per Indian Council of Medical Research (ICMR) and institutional human ethics guidelines. Patients’ and control volunteers’ tear samples were collected after obtaining informed written consent for its research use. The study group was selected from KC patients who reported to the cornea clinic at a tertiary eye hospital in Bangalore, India. A total of 11 KC patients and six healthy control volunteers were enrolled in the study. Patients using contact lenses or systemic anti-inflammatory medications, or systemic inflammatory and autoimmune diseases were excluded from the study. Individuals with a history of ocular surgical intervention (e.g., cataract surgery, vitreoretinal surgery, penetrating keratoplasty/corneal collagen cross-linking) for either eye were also excluded from the study. Patients with recent infection or allergic history were also excluded from the study. All individuals underwent a dry eye evaluation and those patients with signs or symptoms of dry eye disease (as per DEWS classification) were excluded from the study. KC diagnosis was performed by retinoscopy, corneal refraction, and slit lamp biomicroscopy. All patients underwent corneal topography acquired with Pentacam (OCULUS Optikgeräte GmbH, Germany) which was used for grading of the KC patients. Keratometry values for the flat axis (K1), steep axis (K2), mean keratometry (K mean), maximum keratometry (K max), and central corneal thickness (CCT) were established by Scheimpflug image analysis (Pentacam, Oculus Optikgeräte GmbH, Wetzlar, Germany). KC grades were determined by Amsler–Krumeich classification.

Tear fluid collection

Capillary micropipette tubes were used to collect tear samples from all individuals included in the study. Tear collection was done from the outer third of the lower fornix and care was taken to avoid touching the conjunctiva or produce any reflex tearing. Tears were extracted from the micropipette tubes into sterile microfuge tubes and stored at −80°C for further analysis.

Cytometric bead array

Tear cytokine and chemokine measurements were done using cytometric bead array (CBA Human Soluble Protein Flex Set System, BD Biosciences) on a flow cytometer (BD FACSCalibur™, BD Biosciences). The CBA was done for interleukin-1α (IL-1α), IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-9, IL-10, IL-12p70, IL-23p40, IL-13, IL-17A, IL-17F, IL-21, IFNα, IFNγ, CCL2/monocyte chemotactic protein-1, CCL4/MIP-1β, MIP-1α, CCL5/RANTES, CXCL10/IP10, sICAM1, sCD62E/sE-selectin, vascular endothelial growth factor (VEGF), and transforming growth factor β (TGFβ). The experiments were done as per the manufacturer's instruction and analyte signal intensities were calculated with reference to the respective standards and absolute concentrations of individual analytes were calculated using BD FCAP Array Software (BD Biosciences).

Statistical analysis

All statistical analyses were performed with GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA, USA). Shapiro–Wilk normality test was used to check the distribution of the data set. Mann-Whitney test and Kruskal–Wallis test were used to analyze data sets that were not normally distributed. The data are reported as mean ± standard error of the mean (SEM) and P < 0.05 was considered to be statistically significant.

Results

The participants in the study were age (controls – 28.0 ± 3; KC – 28.8 ± 2; mean ± SEM in years)- and sex (M/F; controls – 2/4; KC– 3/8)-matched. The KC patients included in the study had bilateral KC with different grades based on severity. A total of 10 eyes had Grade 1 KC, 7 eyes had Grade 2 KC, and 5 eyes had Grade 3/4 KC. The overall Kmax, Kmean and CCT in KC eyes were 56 ± 2, 50 ± 1, and 430 ± 17, respectively. The Kmax (Grade 1, 49 ± 1; Grade 2, 57 ± 1; Grade 3/4, 69 ± 4) and Kmean (Grade 1, 44 ± 1; Grade 2, 50 ± 1; Grade 3/4, 60 ± 3) increased significantly (P < 0.05, Kruskal–Wallis test) with increasing grades of severity. A significant (P < 0.05, Kruskal–Wallis test) decrease in the CCT (Grade 1, 470 ± 8; Grade 2, 444 ± 12; Grade 3/4, 333 ± 53) was also observed with increasing grades of severity. As shown in Table 1, tear analysis revealed significantly (P < 0.05, Mann–Whitney test) higher levels of inflammation-associated cytokines, chemokines, growth factors, and soluble cell adhesion molecules except for IL-8, IP-10, and VEGF in KC patients. The findings indicate altered inflammatory status or soluble factors milieu in the ocular surface of KC patients compared to controls.
Table 1

Cytokines, chemokines, and growth factor profile in tears of patients with keratoconus as compared to controls

Cytokines, chemokines, and growth factor profile in tears of patients with keratoconus as compared to controls

Discussion

The exact etiopathogenesis of KC is debatable. Although initially described as noninflammatory in nature,[2] eye rubbing, atopy, genetic, and environmental risk factors have been well reported.[39] More recently, the role of inflammation in the pathogenesis of KC has been elucidated.[4101112] The inflammatory process refers to an increase in the vascular permeability and vascular dilatation, which in turn causes exudation of fluid and proteins at the site of inflammation.[13] These processes are not seen in the cornea as it is an avascular structure. However, at the molecular level, the presence of inflammatory cytokines, increased expression of inflammatory proteins and transcription factors point toward the possibility of an active inflammation.[13] Balasubramanian et al. reported an increase in inflammatory factors including IL-6 and MMPs after 60 seconds of eye rubbing.[14] They suggested that habitual eye rubbing for prolonged periods can exacerbate these inflammatory markers and play a role in the progression of KC. The increased shear stress and hydrostatic pressure associated with eye rubbing have also been considered triggers of inflammation.[13] Both shear stress and hydrostatic pressure have a role to play in eye rubbing as well.[15] Another study has reported elevated levels of MMP-9 and IL-6 in patients with KC.[16] We also found elevated levels of inflammatory cytokines and growth factors in tears of patients with KC when compared to controls. Similar results have been reported earlier.[11] LOX enzyme plays an important role in the formation of fibrillar extracellular matrix by oxidative linkage of collagen in the cornea.[17] Deregulation of this enzyme has been reported in several ocular disorders.[18] Dudakova et al. observed LOX activity to be more than 2.5 times lower in KC corneas when compared to normal corneas.[19] Shetty et al. demonstrated a similar finding in a larger cohort and showed that LOX had a reducing trend with increasing severity of KC grades.[20] COLIA1 and COLIVA1 are the major types of collagen required to maintain the normal corneal structure. While COLIA1 is found all across the corneal stroma,[7] COLIVA1 is found predominantly in the epithelial basement membrane.[21] COLIA1 is reduced in the early stages and COLIVA1 is decreased in the advanced stages of KC.[20] This could be responsible for the stromal thinning seen early KC and the thinning of the Bowman's membrane in advanced KC.[22] KC has also been found to be associated with several autoimmune and allergic eye diseases and several factors that contribute to the risk of progression.[2324] In the current study, we demonstrate increased inflammatory factors on the ocular surface which would contribute toward KC and its progression. The knowledge regarding the role of inflammatory factors including cytokines, chemokines, cell adhesion molecules and certain growth factors in influencing the extracellular remodeling is well known. Hence, our findings suggest that inflammation has a plausible role to play in the pathogenesis of KC. This allows us to explore the potential of anti-inflammatory treatment to halt the progression of KC. Multiple studies have shown that cyclosporine A (CsA) has an inhibitory effect on MMPs and the expression of MMP-9 in vitro on human epithelial cells.[162526] It has also been shown to reduce the tear levels of MMP-9[16] and other inflammatory factors. However, the potential role of CsA in KC needs to be explored further. In conclusion, our study demonstrates a potential role of inflammation in KC. Future directions may include targeting these inflammatory factors in the management of KC.

Conclusion

Increased tear fluid inflammatory factors in KC suggests the role of dysregulated inflammation in KC pathogenesis. This opens the potential to explore anti-inflammatory strategies to either halt or delay the progression of KC.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  26 in total

Review 1.  Semantics, inflammation, cytokines and common sense.

Authors:  I Kushner
Journal:  Cytokine Growth Factor Rev       Date:  1998 Sep-Dec       Impact factor: 7.638

2.  Characteristics and associations of keratoconus patients.

Authors:  Mohammad Naderan; Saeed Shoar; Farzaneh Rezagholizadeh; Masoome Zolfaghari; Morteza Naderan
Journal:  Cont Lens Anterior Eye       Date:  2015-02-21       Impact factor: 3.077

Review 3.  Properties and function of lysyl oxidase.

Authors:  H M Kagan; P C Trackman
Journal:  Am J Respir Cell Mol Biol       Date:  1991-09       Impact factor: 6.914

4.  Inflammatory molecules in the tears of patients with keratoconus.

Authors:  Isabel Lema; Juan A Durán
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

5.  The association of keratoconus with immune disorders.

Authors:  Arie Y Nemet; Shlomo Vinker; Irit Bahar; Igor Kaiserman
Journal:  Cornea       Date:  2010-11       Impact factor: 2.651

6.  Effects of eye rubbing on the levels of protease, protease activity and cytokines in tears: relevance in keratoconus.

Authors:  Sivaraman A Balasubramanian; David C Pye; Mark D P Willcox
Journal:  Clin Exp Optom       Date:  2013-02-18       Impact factor: 2.742

Review 7.  Mechanisms of rubbing-related corneal trauma in keratoconus.

Authors:  Charles W McMonnies
Journal:  Cornea       Date:  2009-07       Impact factor: 2.651

8.  Subclinical keratoconus and inflammatory molecules from tears.

Authors:  I Lema; T Sobrino; J A Durán; D Brea; E Díez-Feijoo
Journal:  Br J Ophthalmol       Date:  2009-03-19       Impact factor: 4.638

9.  Differential Molecular Expression of Extracellular Matrix and Inflammatory Genes at the Corneal Cone Apex Drives Focal Weakening in Keratoconus.

Authors:  Natasha Pahuja; Nimisha R Kumar; Rushad Shroff; Rohit Shetty; Rudy M M A Nuijts; Anuprita Ghosh; Abhijit Sinha-Roy; Shyam S Chaurasia; Rajiv R Mohan; Arkasubhra Ghosh
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-10-01       Impact factor: 4.799

Review 10.  Current review and a simplified "five-point management algorithm" for keratoconus.

Authors:  Rohit Shetty; Luci Kaweri; Natasha Pahuja; Harsha Nagaraja; Kareeshma Wadia; Chaitra Jayadev; Rudy Nuijts; Vishal Arora
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

View more
  8 in total

1.  Altered Regulation of mRNA and miRNA Expression in Epithelial and Stromal Tissue of Keratoconus Corneas.

Authors:  Tanja Stachon; Mahsa Nastaranpour; Berthold Seitz; Eckart Meese; Lorenz Latta; Suphi Taneri; Navid Ardjomand; Nóra Szentmáry; Nicole Ludwig
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

2.  Altered tear inflammatory profile in Indian keratoconus patients.

Authors:  Prashant Garg
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

3.  Dopamine levels in human tear fluid.

Authors:  Niyati Seshagiri Sharma; Suraj Kumar Acharya; Archana Padmanabhan Nair; Jyoti Matalia; Rohit Shetty; Arkasubhra Ghosh; Swaminathan Sethu
Journal:  Indian J Ophthalmol       Date:  2019-01       Impact factor: 1.848

4.  The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis.

Authors:  Zulvikar Syambani Ulhaq; Gita Vita Soraya; Lely Retno Wulandari
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

5.  Hypoxic stress increases NF-κB and iNOS mRNA expression in normal, but not in keratoconus corneal fibroblasts.

Authors:  Tanja Stachon; Lorenz Latta; Berthold Seitz; Nóra Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-04       Impact factor: 3.117

6.  Keratoconus patients exhibit a distinct ocular surface immune cell and inflammatory profile.

Authors:  Sharon D'Souza; Archana Padmanabhan Nair; Ganesh Ram Sahu; Tanuja Vaidya; Rohit Shetty; Pooja Khamar; Ritika Mullick; Sneha Gupta; Mor M Dickman; Rudy M M A Nuijts; Rajiv R Mohan; Arkasubhra Ghosh; Swaminathan Sethu
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

7.  Biochemical and molecular alterations and potential clinical applications of biomarkers in keratoconus.

Authors:  Vaitheeswaran G Lalgudi; Rohit Shetty; Kanwal K Nischal; Setareh Ziai; Mona Koaik; Swaminathan Sethu
Journal:  Saudi J Ophthalmol       Date:  2022-04-09

Review 8.  Relevance of IgE, allergy and eye rubbing in the pathogenesis and management of Keratoconus.

Authors:  Prerna Ahuja; Zelda Dadachanji; Rohit Shetty; Sowmya Arudi Nagarajan; Pooja Khamar; Swaminathan Sethu; Sharon D'Souza
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.